Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
NCT06951672

AMEND TS Early Feasibility Study

Led by Valcare Medical Ltd. · Updated on 2026-01-07

15

Participants Needed

11

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Valcare Medical AMEND Trans-Septal System is a mitral valve repair annuloplasty ring implanted in a trans-catheter method intended for correction of mitral regurgitation. It is designed to be used as standalone therapy or in combination with other repair treatments.

CONDITIONS

Official Title

AMEND TS Early Feasibility Study

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient age over 21 years
  • Benefit expected from isolated mitral valve annuloplasty without need for other cardiovascular surgeries
  • Symptomatic functional mitral regurgitation grade 3 or higher
  • NYHA functional class 2 or higher
  • Left ventricular ejection fraction greater than 30% and left ventricular end-diastolic diameter less than 68 mm
  • Meets anatomical criteria for implant size
  • High surgical risk for mitral valve surgery as assessed by heart team
  • Stable on heart failure medications for at least one month
  • Femoral vein and transseptal access feasible
  • Willing to comply with study procedures and follow-up visits
  • Informed consent signed
Not Eligible

You will not qualify if you...

  • Mitral incompetence unsuitable for annuloplasty ring repair
  • Major cardiac or non-cardiac progressive disease increasing risk
  • Life expectancy less than 12 months
  • Non-operable and ineligible for TEER procedure
  • Heavily calcified mitral annulus or leaflets
  • Previous or active endocarditis
  • Active infection
  • Prior prosthetic aortic valve or mitral intervention
  • Cardiovascular intervention within 30 days before procedure
  • Glomerular filtration rate less than 30 ml/min
  • Ischemic coronary event within 30 days before procedure
  • Significant coronary artery disease requiring revascularization
  • Contraindication to general anesthesia
  • Unable to take anti-platelet or anti-coagulant medications
  • Known allergy to nickel
  • Severe allergy to contrast media
  • Significant right ventricle dysfunction
  • Left atrial thrombus
  • Cerebrovascular event within past 12 months
  • Mitral valve anatomy unsuitable for AMEND treatment
  • Pulmonary systolic hypertension with estimated SPAP above 70 mmHg at rest
  • Pregnant or lactating women
  • Drug or alcohol abuse
  • Participation in other investigational research
  • Planned cardiac surgery or interventions within next 7 months
  • Recent implant or revision of cardiac rhythm device within prior month
  • Hypotension or need for inotropic or mechanical support
  • Status 1 or prior heart transplantation
  • Contraindication or high risk for transesophageal echocardiography

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 11 locations

1

Banner University Medical Center - Phoenix

Phoenix, Arizona, United States, 85006

Actively Recruiting

2

Scripps Health

La Jolla, California, United States, 92037

Not Yet Recruiting

3

Piedmont Healthcare

Atlanta, Georgia, United States, 30309

Not Yet Recruiting

4

Ascension St. Vincent

Indianapolis, Indiana, United States, 46260

Actively Recruiting

5

Columbia University Medical Center (CUMC)

New York, New York, United States, 10032

Actively Recruiting

6

Montefiore Medical Center

The Bronx, New York, United States, 10467

Not Yet Recruiting

7

Oregon Health & Science University (OHSU)

Portland, Oregon, United States, 97239

Actively Recruiting

8

Saint Thomas Research Institute

Nashville, Tennessee, United States, 37205

Not Yet Recruiting

9

University of Texas Health Science Center (UTH)

Houston, Texas, United States, 77030

Actively Recruiting

10

Methodist Hospital HCA

San Antonio, Texas, United States, 78229

Actively Recruiting

11

Intermountain Health

Murray, Utah, United States, 84107

Not Yet Recruiting

Loading map...

Research Team

A

Anat Eitan, VP RA & Clinical

CONTACT

M

Madhuri Bhat

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here